Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders

Journal of Gastroenterology

Volumn 32, Issue 3, 1997, Pages 338-343

  Hagihara, Masao ^a   Shimura, Tatsuo ^c   Takebe, Kentaro ^c   Munkhbat, Batmunkh ^a   Hosoi, Katsumi ^a   Kagawa, Tatehiro ^a   Watanabe, Norihito ^a   Matsuzaki, Shohei ^a   Yamamoto, Kozue ^b   Sato, Kaoru ^b   Tsuji, Kimiyoshi ^a  

^a TOKAI UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY HOSPITAL   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Hepatic disorders; Soluble CD8; Soluble HLA class I antigen

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD8 ANTIGEN; HLA ANTIGEN CLASS 1;

ARTICLE; BLOOD LEVEL; CHRONIC ACTIVE HEPATITIS; CHRONIC HEPATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 8244261282     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02934490     Document Type: Article

References (26)

1. Van Rood JJ, van Leeuwen A, van Santen MCT. Anti HLA-A2 inhibitor in normal human serum. Nature 1970;226:366-367.
2. Hagihara M, Shimura T, Yamamoto K, et al. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus. Tokai J Exp Clin Med 1993;18:61-64.
3. Weyand CM, Jendro M, Goronzy JJ. Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders. Autoimmunity 1991;8:281-287.
4. Puppo F, Pellicci R, Brenci S, et al. HLA class I-soluble antigen serum levels in liver transplantation: A predictor marker of acute rejection. Hum Immunol 1994;40:166-170.
5. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, et al. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 1994;40:191-201.
6. Davies HFFS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47:524-527.
7. Brieva JA, Villar LM, Leoro G, et al. Soluble HLA class I antigen secretion by normal lymphocytes: Relationship with cell activation and effect of interferon-gamma. Clin Exp Immunol 1990; 82:390-395.
8. Wijngaard PLJ, Van der Meulen, Meyling FHIG, et al. Soluble CD8 and CD25 in serum of patients after heart transplantation. Clin Exp Immunol 1994;97:505-509.
9. Linker-Israeli M, Hyun S, Ozeri-Chen T, et al. Elevated in vivo and in vitro secretion of CD8- molecules in patients with systemic lupus erythematosus. J Immunol 1994;152:3158-3167.
10. Montano L, Miescher GC, Goodal AH, et al. Hepatitis B virus and HLA display in the liver in chronic hepatitis B virus infection. Hepatology 1982;2:557-561.
11. Fukusato T, Gerber MA, Thung SN, et al. Expression of HLA class I antigens on hepatocyte in liver disease. Am J Pathol 1986;123:264-270,
12. Barbatis C, Woods J, Morton JA, et al. Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. Gut 1981;22:985-991.
13. Manabe K, Yamada G, Nagashima H. Immunohistochemical study of HLA class I antigens on the hepatocytes of patients with chronic hepatitis B. Gastroenterol Jpn 1986;21:357-364.
14. Pignatelli M, Waters J, Broun D, et al. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection. Hepatology 1986;6:349-353.
15. Onji M, Kikuchi T, Kumon I, et al. Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C. Hepato-Gastroenterol 1992;29: 340-343.
16. Dienes HP, Hütteroth T, Hess G, et al. Immunoelectron microscopic observation of the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B, hepatitis. Hepatology 1987;7:1317-1325.
17. Montano L, Aranguibei F, Boffill M, et al. An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis B virus-induced chronic liver disease. Hepatology 1983;3:292-296.
18. Pape GR, Rieber EP, Eisenburg J, et al. Involvement of the cytotoxic/ suppressor T cell subset in liver tissue injury of patients with acute and chronic liver disease. Gastroenterology 1983; 85:657-662.
19. Scheuer PL. Acute and chronic hepatitis revisited: Review by an international group. Lancet 1977;29:914-919.
20. Hiraki DD, See-Tho K, Filvaroff E, et al. Bioengineered soluble HLA-B7. Hum Immunol 1994;40:235-246.
21. Pfeffel F, Pindlich J, Petermann D, et al. Soluble CD8 and soluble CD4 antigens in viral hepatitis and alcoholic cirrhosis. J Hepatol 1994;20:245-251.
22. Wagner F, Assemi C, Lersch C, et al. Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice. Clin Exp Immunol 1990;82:344-349.
23. Sakaguchi K, Koide N, Takenami T, et al. Soluble HLA class I antigens in sera of patients with chronic hepatitis. Gastroenterol Jpn 1992;27:206-211.
24. Onji M, Doi H, Miyaoka T, et al. Serum levels of soluble CD4 and CD8 in patients with chronic vasculitis. Hepato-Gastroenterol 1994;41:377-379.
25. Shimura T, Hagihara M, Yamamoto K, et al. Quantification of serum-soluble HLA class I antigens in patients with gastric cancer. Hum Immunol 1994;40:183-186.
26. Tsuji K. Ss (serum soluble) HLA antigens and their biological significance. Tokai J Exp Clin Med 1979;4:117-129.